{"id":370463,"date":"2025-12-20T16:00:51","date_gmt":"2025-12-20T10:30:51","guid":{"rendered":"https:\/\/www.scconline.com\/blog\/?p=370463"},"modified":"2025-12-20T16:21:47","modified_gmt":"2025-12-20T10:51:47","slug":"shardul-amarchand-mangaldas-advises-nephrocare-nephroplus-ipo","status":"publish","type":"post","link":"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/20\/shardul-amarchand-mangaldas-advises-nephrocare-nephroplus-ipo\/","title":{"rendered":"Shardul Amarchand Mangaldas &#038; Co. advises Nephrocare Health Services Limited on its Initial Public Offering"},"content":{"rendered":"<div style=\"text-align: justify; line-height: 150%;\">\n<p style=\"margin-bottom: 3%;\"><span style=\"font-weight: bold;\">New Delhi | 18th December 2025:<\/span> Shardul Amarchand Mangaldas &amp; Co. (SAM) advised Nephrocare Health Services Limited (&#8220;Nephroplus&#8221;) on its initial public offering aggregating to approximately US$ 95.99 million (&#8377; 8,710.48 million), comprising a fresh issue of &#8377; 3,534.05 million and an offer for sale of &#8377; 5,176.43 million.<\/p>\n<p style=\"margin-bottom: 3%;\">SAM acted as legal counsel to Nephroplus on Indian law aspects of the transaction, advising on the drafting and regulatory compliance for the IPO, including coordination with multiple domestic and international stakeholders and supporting the company through the prospectus filing and listing process.<\/p>\n<p style=\"margin-bottom: 3%;\">The SAM team was led by Prashant Gupta, National Practice Head &#8212; Capital Markets and Devi Prasad Patel, Partner; and assisted by Divya Dhawan, Associate; Satakshi N. Dixit, Associate; and Arjun Bhatia, Associate.<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p style=\"font-style: italic;\">Shardul Amarchand Mangaldas advised Nephrocare Health Services Limited (Nephroplus) on its initial public offering aggregating to approximately US$ 95.99 million, covering Indian law, regulatory compliance, and prospectus and listing support.<\/p>\n","protected":false},"author":67011,"featured_media":370471,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[45282,2],"tags":[92619,95308,95358,95355,95356,95359,95357,94204,46701],"class_list":["post-370463","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-law-firms-news","category-news","tag-capital-markets-india","tag-healthcare-ipo-india","tag-indian-ipo-legal-advisors","tag-nephrocare-health-services-ipo","tag-nephroplus-ipo","tag-public-issue-india","tag-sam-ipo-advisory","tag-sebi-ipo-compliance","tag-shardul-amarchand-mangaldas"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.4 (Yoast SEO v27.4) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Shardul Amarchand Mangaldas Advises Nephrocare (Nephroplus) on IPO | SCC Times<\/title>\n<meta name=\"description\" content=\"Shardul Amarchand Mangaldas advised Nephrocare Health Services (Nephroplus) on its US$ 95.99 million initial public offering.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/20\/shardul-amarchand-mangaldas-advises-nephrocare-nephroplus-ipo\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Shardul Amarchand Mangaldas advises Nephrocare Health Services Limited on its Initial Public Offering\" \/>\n<meta property=\"og:description\" content=\"Shardul Amarchand Mangaldas advised Nephrocare Health Services (Nephroplus) on its US$ 95.99 million initial public offering.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/20\/shardul-amarchand-mangaldas-advises-nephrocare-nephroplus-ipo\/\" \/>\n<meta property=\"og:site_name\" content=\"SCC Times\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/scc.online\/\" \/>\n<meta property=\"article:published_time\" content=\"2025-12-20T10:30:51+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-12-20T10:51:47+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/12\/blog-22-13.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"886\" \/>\n\t<meta property=\"og:image:height\" content=\"590\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Editor\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"Shardul Amarchand Mangaldas &amp; Co. advises Nephrocare Health Services Limited on its Initial Public Offering\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Editor\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/post\\\/2025\\\/12\\\/20\\\/shardul-amarchand-mangaldas-advises-nephrocare-nephroplus-ipo\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/post\\\/2025\\\/12\\\/20\\\/shardul-amarchand-mangaldas-advises-nephrocare-nephroplus-ipo\\\/\"},\"author\":{\"name\":\"Editor\",\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/#\\\/schema\\\/person\\\/84e42bab48238baf12c7e33b3d9761fe\"},\"headline\":\"Shardul Amarchand Mangaldas &#038; Co. advises Nephrocare Health Services Limited on its Initial Public Offering\",\"datePublished\":\"2025-12-20T10:30:51+00:00\",\"dateModified\":\"2025-12-20T10:51:47+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/post\\\/2025\\\/12\\\/20\\\/shardul-amarchand-mangaldas-advises-nephrocare-nephroplus-ipo\\\/\"},\"wordCount\":129,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/post\\\/2025\\\/12\\\/20\\\/shardul-amarchand-mangaldas-advises-nephrocare-nephroplus-ipo\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/blog-22-13.webp\",\"keywords\":[\"Capital Markets India\",\"Healthcare IPO India\",\"Indian IPO Legal Advisors\",\"Nephrocare Health Services IPO\",\"Nephroplus IPO\",\"Public Issue India\",\"SAM IPO Advisory\",\"SEBI IPO compliance\",\"Shardul Amarchand Mangaldas\"],\"articleSection\":[\"Law Firms News\",\"News\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.scconline.com\\\/blog\\\/post\\\/2025\\\/12\\\/20\\\/shardul-amarchand-mangaldas-advises-nephrocare-nephroplus-ipo\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/post\\\/2025\\\/12\\\/20\\\/shardul-amarchand-mangaldas-advises-nephrocare-nephroplus-ipo\\\/\",\"url\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/post\\\/2025\\\/12\\\/20\\\/shardul-amarchand-mangaldas-advises-nephrocare-nephroplus-ipo\\\/\",\"name\":\"Shardul Amarchand Mangaldas Advises Nephrocare (Nephroplus) on IPO | SCC Times\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/post\\\/2025\\\/12\\\/20\\\/shardul-amarchand-mangaldas-advises-nephrocare-nephroplus-ipo\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/post\\\/2025\\\/12\\\/20\\\/shardul-amarchand-mangaldas-advises-nephrocare-nephroplus-ipo\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/blog-22-13.webp\",\"datePublished\":\"2025-12-20T10:30:51+00:00\",\"dateModified\":\"2025-12-20T10:51:47+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/#\\\/schema\\\/person\\\/84e42bab48238baf12c7e33b3d9761fe\"},\"description\":\"Shardul Amarchand Mangaldas advised Nephrocare Health Services (Nephroplus) on its US$ 95.99 million initial public offering.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/post\\\/2025\\\/12\\\/20\\\/shardul-amarchand-mangaldas-advises-nephrocare-nephroplus-ipo\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.scconline.com\\\/blog\\\/post\\\/2025\\\/12\\\/20\\\/shardul-amarchand-mangaldas-advises-nephrocare-nephroplus-ipo\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/post\\\/2025\\\/12\\\/20\\\/shardul-amarchand-mangaldas-advises-nephrocare-nephroplus-ipo\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/blog-22-13.webp\",\"contentUrl\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/blog-22-13.webp\",\"width\":886,\"height\":590,\"caption\":\"Nephrocare Nephroplus IPO\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/post\\\/2025\\\/12\\\/20\\\/shardul-amarchand-mangaldas-advises-nephrocare-nephroplus-ipo\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Shardul Amarchand Mangaldas &#038; Co. advises Nephrocare Health Services Limited on its Initial Public Offering\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/#website\",\"url\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/\",\"name\":\"SCC Times\",\"description\":\"Bringing you the Best Analytical Legal News\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/#\\\/schema\\\/person\\\/84e42bab48238baf12c7e33b3d9761fe\",\"name\":\"Editor\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/34e366be721c41333586de05faa13743195f5b142dcd7a015c6fabd2389521d0?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/34e366be721c41333586de05faa13743195f5b142dcd7a015c6fabd2389521d0?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/34e366be721c41333586de05faa13743195f5b142dcd7a015c6fabd2389521d0?s=96&d=mm&r=g\",\"caption\":\"Editor\"},\"url\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/post\\\/author\\\/editor_4\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Shardul Amarchand Mangaldas Advises Nephrocare (Nephroplus) on IPO | SCC Times","description":"Shardul Amarchand Mangaldas advised Nephrocare Health Services (Nephroplus) on its US$ 95.99 million initial public offering.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/20\/shardul-amarchand-mangaldas-advises-nephrocare-nephroplus-ipo\/","og_locale":"en_US","og_type":"article","og_title":"Shardul Amarchand Mangaldas advises Nephrocare Health Services Limited on its Initial Public Offering","og_description":"Shardul Amarchand Mangaldas advised Nephrocare Health Services (Nephroplus) on its US$ 95.99 million initial public offering.","og_url":"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/20\/shardul-amarchand-mangaldas-advises-nephrocare-nephroplus-ipo\/","og_site_name":"SCC Times","article_publisher":"https:\/\/www.facebook.com\/scc.online\/","article_published_time":"2025-12-20T10:30:51+00:00","article_modified_time":"2025-12-20T10:51:47+00:00","og_image":[{"width":886,"height":590,"url":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/12\/blog-22-13.jpg","type":"image\/jpeg"}],"author":"Editor","twitter_card":"summary_large_image","twitter_title":"Shardul Amarchand Mangaldas & Co. advises Nephrocare Health Services Limited on its Initial Public Offering","twitter_misc":{"Written by":"Editor","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/20\/shardul-amarchand-mangaldas-advises-nephrocare-nephroplus-ipo\/#article","isPartOf":{"@id":"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/20\/shardul-amarchand-mangaldas-advises-nephrocare-nephroplus-ipo\/"},"author":{"name":"Editor","@id":"https:\/\/www.scconline.com\/blog\/#\/schema\/person\/84e42bab48238baf12c7e33b3d9761fe"},"headline":"Shardul Amarchand Mangaldas &#038; Co. advises Nephrocare Health Services Limited on its Initial Public Offering","datePublished":"2025-12-20T10:30:51+00:00","dateModified":"2025-12-20T10:51:47+00:00","mainEntityOfPage":{"@id":"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/20\/shardul-amarchand-mangaldas-advises-nephrocare-nephroplus-ipo\/"},"wordCount":129,"commentCount":0,"image":{"@id":"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/20\/shardul-amarchand-mangaldas-advises-nephrocare-nephroplus-ipo\/#primaryimage"},"thumbnailUrl":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/12\/blog-22-13.webp","keywords":["Capital Markets India","Healthcare IPO India","Indian IPO Legal Advisors","Nephrocare Health Services IPO","Nephroplus IPO","Public Issue India","SAM IPO Advisory","SEBI IPO compliance","Shardul Amarchand Mangaldas"],"articleSection":["Law Firms News","News"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.scconline.com\/blog\/post\/2025\/12\/20\/shardul-amarchand-mangaldas-advises-nephrocare-nephroplus-ipo\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/20\/shardul-amarchand-mangaldas-advises-nephrocare-nephroplus-ipo\/","url":"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/20\/shardul-amarchand-mangaldas-advises-nephrocare-nephroplus-ipo\/","name":"Shardul Amarchand Mangaldas Advises Nephrocare (Nephroplus) on IPO | SCC Times","isPartOf":{"@id":"https:\/\/www.scconline.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/20\/shardul-amarchand-mangaldas-advises-nephrocare-nephroplus-ipo\/#primaryimage"},"image":{"@id":"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/20\/shardul-amarchand-mangaldas-advises-nephrocare-nephroplus-ipo\/#primaryimage"},"thumbnailUrl":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/12\/blog-22-13.webp","datePublished":"2025-12-20T10:30:51+00:00","dateModified":"2025-12-20T10:51:47+00:00","author":{"@id":"https:\/\/www.scconline.com\/blog\/#\/schema\/person\/84e42bab48238baf12c7e33b3d9761fe"},"description":"Shardul Amarchand Mangaldas advised Nephrocare Health Services (Nephroplus) on its US$ 95.99 million initial public offering.","breadcrumb":{"@id":"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/20\/shardul-amarchand-mangaldas-advises-nephrocare-nephroplus-ipo\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.scconline.com\/blog\/post\/2025\/12\/20\/shardul-amarchand-mangaldas-advises-nephrocare-nephroplus-ipo\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/20\/shardul-amarchand-mangaldas-advises-nephrocare-nephroplus-ipo\/#primaryimage","url":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/12\/blog-22-13.webp","contentUrl":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/12\/blog-22-13.webp","width":886,"height":590,"caption":"Nephrocare Nephroplus IPO"},{"@type":"BreadcrumbList","@id":"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/20\/shardul-amarchand-mangaldas-advises-nephrocare-nephroplus-ipo\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.scconline.com\/blog\/"},{"@type":"ListItem","position":2,"name":"Shardul Amarchand Mangaldas &#038; Co. advises Nephrocare Health Services Limited on its Initial Public Offering"}]},{"@type":"WebSite","@id":"https:\/\/www.scconline.com\/blog\/#website","url":"https:\/\/www.scconline.com\/blog\/","name":"SCC Times","description":"Bringing you the Best Analytical Legal News","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.scconline.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.scconline.com\/blog\/#\/schema\/person\/84e42bab48238baf12c7e33b3d9761fe","name":"Editor","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/34e366be721c41333586de05faa13743195f5b142dcd7a015c6fabd2389521d0?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/34e366be721c41333586de05faa13743195f5b142dcd7a015c6fabd2389521d0?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/34e366be721c41333586de05faa13743195f5b142dcd7a015c6fabd2389521d0?s=96&d=mm&r=g","caption":"Editor"},"url":"https:\/\/www.scconline.com\/blog\/post\/author\/editor_4\/"}]}},"jetpack_featured_media_url":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/12\/blog-22-13.webp","jetpack_sharing_enabled":true,"jetpack-related-posts":[],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/posts\/370463","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/users\/67011"}],"replies":[{"embeddable":true,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/comments?post=370463"}],"version-history":[{"count":0,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/posts\/370463\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/media\/370471"}],"wp:attachment":[{"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/media?parent=370463"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/categories?post=370463"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/tags?post=370463"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}